Glimepirideand insulin-induced glycosylphosphatidylinositol-specific phospholipase C regulation

Details for Australian Patent Application No. 2005215886 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Mueller, Guenter; Frick, Wendelin; Schneider, Rudolf

Agent Watermark

Pub. Number AU-B-2005215886

PCT Pub. Number WO2005/080587

Priority 04003897.8 20.02.04 EP

Filing date 16 February 2005

Wipo publication date 1 September 2005

Acceptance publication date 22 July 2010

International Classifications

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C07F 9/6571 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C12Q 1/34 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/080587 Priority application(s): WO2005/080587

22 July 2010 Application Accepted

  Published as AU-B-2005215886

18 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005215889-Highly active glycoproteins-process conditions and an efficient method for their production

2005215881-Ionic UV-A sunscreens and compositions containing them